Inozyme Pharma to Present Recently Announced Preliminary Data from Ongoing Phase 1/2 Trial in ENPP1 Deficiency at the European Calcified Tissue Society Congress (ECTS)
BOSTON, April 14, 2023 (GLOBE NEWSWIRE) — Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease…
Gigamon Extends the Deep Observability Pipeline for AI-Enabled Network and Security Operations with New GigaSMART Network Appliance